A Randomized Controlled Clinical Trial Comparing 20 Gauge and 23 Gauge Vitrectomy for Patients with Macular Hole or Macular Pucker
Paula Scholz, Philipp S Müther, Petra Schiller, Moritz Felsch, Sascha Fauser, Paula Scholz, Philipp S Müther, Petra Schiller, Moritz Felsch, Sascha Fauser
Abstract
Introduction: To compare the transconjunctival sutureless 23 gauge (G) pars plana vitrectomy (PPV) with 20 G PPV regarding inflammation, safety, visual outcome and patient comfort.
Methods: We included 103 patients with symptomatic macular hole or macular pucker, scheduled for vitrectomy in this prospective, randomized, controlled, mono-center clinical trial. Patients were randomized 1:1 to either 20G PPV (n = 51) or 23G PPV (n = 52). All eyes underwent standard 20G or 23G PPV with membrane peeling. Primary outcome measure was change in aqueous humor flare 3 weeks after surgery compared with baseline. Secondary outcome measures were flare values 2 days and 26 weeks after surgery, subjective discomforts measured with a visual analog scale, best-corrected visual acuity, duration of surgery, intraocular pressure (IOP) and adverse events.
Results: There was no significant difference in change of flare 3 weeks after PPV [- 1.7, 95% CI (- 6.3 to 2.9), p = 0.466]. Both groups showed a significant increase in flare 2 days after surgery (20G: p < 0.001, 23G: p = 0.002), but only the 20G group after 3 weeks (p = 0.011). The gain in visual acuity after 3 weeks was higher after 23G PPV (4.2 95% CI (0.4-8.0, p = 0.029), but without a difference after 6 months. The duration of surgery was shorter in the 23G group (p < 0.001). Patient comfort 3 weeks after surgery was greater after 23G PPV (foreign body sensation p = 0.002; itching: p = 0.021). However, the rate of complications did not differ between the groups.
Conclusion: The primary aim, showing the superiority of the 23G group regarding the change of flare value from baseline to 3 weeks after surgery, was not met, but the level of inflammation decreased faster after 23G PPV. Clear advantages of the 23G PPV were a lower risk of postoperative IOP elevation, a shorter surgery time, faster visual recovery and greater patient comfort in the early postoperative phase.
Clinical trial registration number: ClinicalTrials.gov NCT01969929.
Keywords: 20 Gauge; 23 Gauge; Adverse events; Macular hole; Macular pucker; Randomized controlled clinical trial; Vitrectomy.
Figures
References
- Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina. 2005;25(2):208–211. doi: 10.1097/00006982-200502000-00015.
- Mentens R, Stalmans P. Comparison of postoperative comfort in 20 gauge versus 23 gauge pars plana vitrectomy. Bull Soc Belge Ophtalmol. 2009;311:5–10.
- Misra A, Ho-yen G, Burton R. 23-Gauge sutureless vitrectomy and 20-gauge vitrectomy: a case series comparison. Eye. 2009;23(5):1187. doi: 10.1038/eye.2008.175.
- Haas A, Seidel G, Steinbrugger I, Maier R, Gasser-Steiner V, Wedrich A, et al. Twenty-three-gauge and 20-gauge vitrectomy in epiretinal membrane surgery. Retina. 2010;30(1):112–116. doi: 10.1097/IAE.0b013e3181b32ebf.
- Krishnan R, Tossounis C, Yang YF. 20-Gauge and 23-gauge phacovitrectomy for idiopathic macular holes: comparison of complications and long-term outcomes. Eye. 2012;27(1):72. doi: 10.1038/eye.2012.227.
- Hikichi T, Matsumoto N, Ohtsuka H, Higuchi M, Matsushita T, Ariga H, et al. Comparison of one-year outcomes between 23-and 20-gauge vitrectomy for preretinal membrane. Am J Ophthalmol. 2009;147(4):639–643. doi: 10.1016/j.ajo.2008.10.009.
- Chylack LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The lens opacities classification system III. Arch Ophthalmol. 1993;111(6):831–836. doi: 10.1001/archopht.1993.01090060119035.
- Faul F, Erdfelder E, Lang A-G, Buchner A. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191. doi: 10.3758/BF03193146.
- Krishnan R, Tossounis C, Yang YF. 20-gauge and 23-gauge phacovitrectomy for idiopathic macular holes: comparison of complications and long-term outcomes. Eye. 2013;27(1):72–77. doi: 10.1038/eye.2012.227.
- Rizzo S, Genovesi-Ebert F, Murri S, Belting C, Vento A, Cresti F, et al. 25-gauge, sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefe’s Arch Clin Exp Ophthalmol. 2006;244(4):472–479. doi: 10.1007/s00417-005-0173-6.
- Narayanan R, Sinha A, Reddy RK, Krishnaiah S, Kuppermann BD. Faster visual recovery after 23-gauge vitrectomy compared with 20-gauge vitrectomy. Retina. 2010;30(9):1511–1514. doi: 10.1097/IAE.0b013e3181dee007.
- Okamoto F, Okamoto C, Sakata N, Hiratsuka K, Yamane N, Hiraoka T, et al. Changes in corneal topography after 25-gauge transconjunctival sutureless vitrectomy versus after 20-gauge standard vitrectomy. Ophthalmology. 2007;114(12):2138–2141. doi: 10.1016/j.ophtha.2007.01.034.
- Kadonosono K, Yamakawa T, Uchio E, Yanagi Y, Tamaki Y, Araie M. Comparison of visual function after epiretinal membrane removal by 20-gauge and 25-gauge vitrectomy. Am J Ophthalmol. 2006;142(3):513–515. doi: 10.1016/j.ajo.2006.03.060.
- Desai UR, Alhalel AA, Schiffman RM, Campen TJ, Sundar G, Muhich A. Intraocular pressure elevation after simple pars plana vitrectomy. Ophthalmology. 1997;104(5):781–786. doi: 10.1016/S0161-6420(97)30233-4.
- Gosse E, Newsom R, Hall P, Lochhead J. Changes in day 1 post-operative intraocular pressure following sutureless 23-gauge and conventional 20-gauge pars plana vitrectomy. Open Ophthalmol J. 2013;7:42. doi: 10.2174/1874364101307010042.
- Thompson JT. Does vitrectomy increase the risk of glaucoma? LWW. 2011.
- Melberg NS, Thomas MA. Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology. 1995;102(10):1466–1471. doi: 10.1016/S0161-6420(95)30844-5.
- Cherfan GM, Michels RG, de Bustros S, Enger C, Glaser BM. Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol. 1991;111(4):434–438. doi: 10.1016/S0002-9394(14)72377-3.
Source: PubMed